НовостиBenzingaPiper Sandler Maintains Neutral on Caris Life Sciences, Raises Price Target to $25 Piper Sandler Maintains Neutral on Caris Life Sciences, Raises Price Target to $25 Benzinga 2026.11.10 12:53 (GMT+0) Открыть на Benzinga Другие новости